Last update March 29, 2023

Meglumine Ioxitalamate

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

The X-ray contrast media with components like Oxitalamic acid, Meglumine and Sodium have a content of Iodine between 45 and 59%.

At latest update no published data were found on excretion into breast milk.

It is also used in the pediatric age.

The various Iodinated contrast media for imaging examinations (X-rays, CT scans) are considered compatible with breastfeeding since they are rapidly eliminated with little or no release of iodine, not metabolized and virtually not absorbed when taken by mouth. They are structurally very similar to each other and one of them is their data no or minimal excretion in milk.

Given the low lipid solubility of the iodinated contrast, less than 1% of the dose administered to the mother just passing milk. Due to their low oral bioavailability, intestinal absorption is less than 1% of the dose that he may take the infant. The maximum dose just getting the baby is less than 0.01% of the maternal dose, which represents less than 1% of the dose administered to a nursing practice that is a radiological contrast examination.

Most experts and radiology scientific societies agree that after a radiological iodinated contrast examination is not necessary to wait no time to nurse.


See below the information of this related product:

Alternatives

  • Amidotrizoate ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Iohexol ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Meglumine Ioxitalamate is also known as


Meglumine Ioxitalamate in other languages or writings:

Group

Meglumine Ioxitalamate belongs to this group or family:

Tradenames

Main tradenames from several countries containing Meglumine Ioxitalamate in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 0 %
Molecular weight 643 - 839 daltons
Protein Binding < 27 %
VD 0.19 l/Kg
pKa 2.13 -
1.1 hours

References

  1. LIebel F. Ioxitalamate. Drug Summary. 2017 Full text (in our servers)

Total visits

4,226

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by El Parto Es Nuestro of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM